181 related articles for article (PubMed ID: 31063355)
1. JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.
Du L; Anderson A; Nguyen K; Ojeda SS; Ortiz-Rivera I; Nguyen TN; Zhang T; Kaoud TS; Gray NS; Dalby KN; Tsai KY
ACS Chem Biol; 2019 Jul; 14(7):1426-1435. PubMed ID: 31063355
[TBL] [Abstract][Full Text] [Related]
2. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.
Bost F; McKay R; Bost M; Potapova O; Dean NM; Mercola D
Mol Cell Biol; 1999 Mar; 19(3):1938-49. PubMed ID: 10022881
[TBL] [Abstract][Full Text] [Related]
3. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
5. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
[TBL] [Abstract][Full Text] [Related]
8. Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.
Lu W; Liu Y; Gao Y; Geng Q; Gurbani D; Li L; Ficarro SB; Meyer CJ; Sinha D; You I; Tse J; He Z; Ji W; Che J; Kim AY; Yu T; Wen K; Anderson KC; Marto JA; Westover KD; Zhang T; Gray NS
J Med Chem; 2023 Mar; 66(5):3356-3371. PubMed ID: 36826833
[TBL] [Abstract][Full Text] [Related]
9. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1.
Yao K; Chen H; Lee MH; Li H; Ma W; Peng C; Song NR; Lee KW; Bode AM; Dong Z; Dong Z
Cancer Prev Res (Phila); 2014 Jan; 7(1):139-49. PubMed ID: 24253317
[TBL] [Abstract][Full Text] [Related]
11. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
12. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2.
Takatori A; Geh E; Chen L; Zhang L; Meller J; Xia Y
Development; 2008 Jan; 135(1):23-32. PubMed ID: 18032450
[TBL] [Abstract][Full Text] [Related]
13. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
Wang X; Wu D; Yang L; Cederbaum AI
Hepatology; 2011 Nov; 54(5):1753-66. PubMed ID: 21748763
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.
Gao X; Wu X; Yan J; Zhang J; Zhao W; DeMarco D; Zhang Y; Bakhos M; Mignery G; Sun J; Li Z; Fill M; Ai X
Cardiovasc Res; 2018 Apr; 114(5):737-746. PubMed ID: 29360953
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.
Varona-Santos JL; Pileggi A; Molano RD; Sanabria NY; Ijaz A; Atsushi M; Ichii H; Pastori RL; Inverardi L; Ricordi C; Fornoni A
Diabetologia; 2008 Dec; 51(12):2271-80. PubMed ID: 18853132
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
18. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.
Tuncman G; Hirosumi J; Solinas G; Chang L; Karin M; Hotamisligil GS
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10741-6. PubMed ID: 16818881
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
[TBL] [Abstract][Full Text] [Related]
20. JNK2: a negative regulator of cellular proliferation.
Sabapathy K; Wagner EF
Cell Cycle; 2004 Dec; 3(12):1520-3. PubMed ID: 15611655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
